PUBLIC COMPANY
save$HRTXHERON THERAPEUTICS, INC. /DE/
$HRTX0.5114+3.06%San Diego, CA, USupdated 17d ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
2
approvals ytd
1
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Unknown
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2Pilot Herniorrhaphy Study for Postoperative Analgesia
- phase2Phase 2B Upper Extremity Nerve Block Study
- phase3Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)
- phase3APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
- phase2Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia
- phase2Phase 2 Herniorrhaphy Study for Opioid Elimination
- phase3A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC
- phase3Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen
Insider activity
source: SEC Form 4routine RSU / option mechanics (6)
- Apr 19, 26option exerciseForbes William P · EVP, Chief Development Officer3,874 sh
- Apr 19, 26option exerciseForbes William P · EVP, Chief Development Officer3,874 sh
- Apr 19, 26option exerciseCollard Craig A · Chief Executive Officer13,797 sh
- Apr 19, 26option exerciseCollard Craig A · Chief Executive Officer13,797 sh
- Apr 19, 26option exerciseDuarte Ira · EVP, Chief Financial Officer3,874 sh
- Apr 19, 26option exerciseDuarte Ira · EVP, Chief Financial Officer3,874 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 18m ago
Found something off?
comments(0)
5-min edit window · permanent after that